Literature DB >> 24748183

Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis.

Roy Liu1, Kristen Cox, Stephen L Guthery, Linda Book, Benjamin Witt, Barbara Chadwick, Douglas G Adler.   

Abstract

INTRODUCTION: Cholangiocarcinoma (CCA) is very often an adulthood disease with primary sclerosing cholangitis (PSC) as one of the risk factors. It is rarely seen in the pediatric population, and when it is diagnosed before adulthood, it can be associated with PSC as well as HIV infection, biliary atresia, radiation therapy, and choledochal cyst. Although there have been some case reports of pediatric CCA, cases of childhood CCA associated with PSC are still relatively rare. AIM: To describe the clinical and pathologic features of CCA in pediatric patients with previously diagnosed PSC.
METHODS: Retrospective study
RESULTS: Four patients with PSC (age range 15-18, mean 17 years) were included in this study. All patients underwent ERCP for diagnosis. Tissue samples obtained included routine cytology and FISH. ERCP was used to target sites for tissue acquisition in all patients. 3/4 of patients have inflammatory bowel disease (two Crohn's disease and one ulcerative colitis). Alkaline phosphatase was elevated in 3/4 patients, aspartate aminotransferase/alanine aminotransferase were elevated in 2/4 patients, and total bilirubin/direct bilirubin were elevated in 2/4 patients. 4/4 patients had positive FISH studies, and 3/4 patients had brush cytology concerning for CCA. 2/4 patients received chemotherapy, one patient underwent orthotopic liver transplant, and one patient underwent Whipple procedure. Two patients died soon after being diagnosed.
CONCLUSIONS: Young patients with PSC can develop CCA. This finding has implications for both screening and surveillance for cancer in pediatric patients with PSC.

Entities:  

Mesh:

Year:  2014        PMID: 24748183     DOI: 10.1007/s10620-014-3152-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Choledochal cystic malignancies.

Authors:  H Bismuth; J Krissat
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

2.  Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?

Authors:  P C de Groen
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

3.  Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures.

Authors:  Laura E Moreno Luna; Benjamin Kipp; Kevin C Halling; Thomas J Sebo; Walter K Kremers; Lewis R Roberts; Emily G Barr Fritcher; Michael J Levy; Gregory J Gores
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

4.  Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Authors:  Emily G Barr Fritcher; Jesse S Voss; Sarah M Jenkins; Ravi K Lingineni; Amy C Clayton; Lewis R Roberts; Kevin C Halling; Jayant A Talwalkar; Gregory J Gores; Benjamin R Kipp
Journal:  Cancer Cytopathol       Date:  2013-07-09       Impact factor: 5.284

5.  Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.

Authors:  Emily G Barr Fritcher; Benjamin R Kipp; Jesse S Voss; Amy C Clayton; Keith D Lindor; Kevin C Halling; Gregory J Gores
Journal:  Am J Gastroenterol       Date:  2011-08-16       Impact factor: 10.864

6.  Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

Authors:  U Broomé; R Olsson; L Lööf; G Bodemar; R Hultcrantz; A Danielsson; H Prytz; H Sandberg-Gertzén; S Wallerstedt; G Lindberg
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Cholangiocarcinoma complicating primary sclerosing cholangitis.

Authors:  C B Rosen; D M Nagorney; R H Wiesner; R J Coffey; N F LaRusso
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

8.  Cholangiocarcinoma associated with biliary cirrhosis due to congenital biliary atresia.

Authors:  P B Kulkarni; E Beatty
Journal:  Am J Dis Child       Date:  1977-04

9.  Risk factors and classifications of hilar cholangiocarcinoma.

Authors:  Miguel Angel Suarez-Munoz; Jose Luis Fernandez-Aguilar; Belinda Sanchez-Perez; Jose Antonio Perez-Daga; Beatriz Garcia-Albiach; Ysabel Pulido-Roa; Naiara Marin-Camero; Julio Santoyo-Santoyo
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

10.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

View more
  8 in total

Review 1.  Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.

Authors:  Vennisvasanth Lourdusamy; Benjamin Tharian; Udayakumar Navaneethan
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

2.  Cytologic Diagnosis of Biliary Strictures: FISH or Cut the Sensitivity Rate?

Authors:  Douglas G Adler; Benjamin Witt
Journal:  Dig Dis Sci       Date:  2018-03       Impact factor: 3.199

Review 3.  Update on the Diagnosis and Treatment of Cholangiocarcinoma.

Authors:  Bryan Doherty; Vinod E Nambudiri; William C Palmer
Journal:  Curr Gastroenterol Rep       Date:  2017-01

Review 4.  Cancer review: Cholangiocarcinoma.

Authors:  Yezaz Ahmed Ghouri; Idrees Mian; Boris Blechacz
Journal:  J Carcinog       Date:  2015-02-23

5.  Cholangiocarcinoma in a Child with Progressive Abdominal Distension and Secondary Hypercalcemia.

Authors:  Chalinee Monsereenusorn; Kantang Satayasoontorn; Piya Rujkijyanont; Chanchai Traivaree
Journal:  Case Rep Pediatr       Date:  2018-04-23

6.  [Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients].

Authors:  Vittorio Branchi; Tobias J Weismüller; Taotao Zhou; Jonas Henn; Alexander Semaan; Tim R Glowka; Maria Gonzalez-Carmona; Christian Strassburg; Jörg C Kalff; Steffen Manekeller; Hanno Matthaei
Journal:  Chirurg       Date:  2021-02       Impact factor: 0.955

7.  Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study.

Authors:  Udayakumar Navaneethan; Vennisvasanth Lourdusamy; Preethi Gk Venkatesh; Belinda Willard; Madhusudhan R Sanaka; Mansour A Parsi
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-09

Review 8.  Treatment of primary sclerosing cholangitis in children.

Authors:  Trevor J Laborda; M Kyle Jensen; Marianne Kavan; Mark Deneau
Journal:  World J Hepatol       Date:  2019-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.